Thank you, Mr. Chair.
The point I was making is that Canada worked in multiple regards to support access to vaccines and their distribution and use in low- and middle-income countries, first through being a leading donor to COVAX, right from the very beginning in 2020. Additionally, Canada provided funds through COVAX and bilaterally with countries to support their vaccine programs—information, distribution and uptake in clinics. Thirdly, as we've been discussing, Canada provided doses through to COVAX and bilaterally with countries. Those elements have supported and helped low- and middle-income countries.
The investments we have made through Global Affairs to support information and support trusted people in communities on vaccine uptake have been important, recognizing some of the challenges in uptake in those countries, as has been noted.